Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Christopher Butler, PANORAMIC Trial Collaborative Group‡, GREG IRVING

Research output: Contribution to journal › Article (journal) › peer-review

234 Citations (Scopus)
49 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases